» Articles » PMID: 36660894

Plasma Inflammation-related Biomarkers Are Associated with Intrinsic Capacity in Community-dwelling Older Adults

Overview
Date 2023 Jan 20
PMID 36660894
Authors
Affiliations
Soon will be listed here.
Abstract

Background: How inflammation relates to intrinsic capacity (IC), the composite of physical and mental capacities, remains undefined. Our study aimed to investigate the cross-sectional and longitudinal associations between plasma inflammation-related biomarkers and IC in older adults.

Methods: This secondary analysis of the Multidomain Alzheimer Preventive Trial (MAPT) included 1238 community-dwelling older individuals with IC assessments from 12 to 60 months. Plasma C-reactive protein (CRP), interleukin-6 (IL-6), tumour necrosis factor receptor-1 (TNFR-1), monocyte chemoattractant protein-1 (MCP-1) and growth differentiation factor-15 (GDF-15) were measured at 12 months. IC was operationalized as a score ranging from 0 to 100, derived from four domains: cognition, Mini-Mental State Examination; locomotion, Short Physical Performance Battery; psychological, Geriatric Depression Scale; and vitality, handgrip strength. A five-domain IC score (plus sensory) was investigated in a subsample (n = 535) with a 1-year follow-up as an exploratory outcome.

Results: The mean age of the 1238 participants was 76.2 years (SD = 4.3); 63.7% were female. Their initial four-domain IC scores averaged 78.9 points (SD = 9.3), with a yearly decline of 1.17 points (95% CI = -1.30 to -1.05; P < 0.001). We observed significant associations of lower baseline IC with higher CRP, IL-6, TNFR-1 and GDF-15, after controlling age, sex, MAPT group allocation and educational level [CRP: adjusted β (95% CI) = -1.56 (-2.64 to -0.48); P = 0.005; IL-6: adjusted β = -3.16 (-4.82 to -1.50); P < 0.001; TNFR-1: adjusted β = -6.86 (-10.25 to -3.47); P < 0.001; GDF-15: adjusted β = -7.07 (-10.02 to -4.12); P < 0.001]. Higher TNFR-1, MCP-1 and GDF-15 were associated with faster decline in four-domain IC over 4 years [TNFR-1: adjusted β (95% CI) = -1.28 (-2.29 to -0.27); P = 0.013; MCP-1: adjusted β = -1.33 (-2.24 to -0.42); P = 0.004; GDF-15: adjusted β = -1.42 (-2.26 to -0.58); P = 0.001]. None of the biomarkers was significantly associated with the five-domain IC decline.

Conclusions: Inflammation was associated with lower IC in older adults. Among all plasma biomarkers, TNFR-1 and GDF-15 were consistently associated with IC at the cross-sectional and longitudinal levels.

Citing Articles

Mechanisms and pharmacotherapy of cancer cachexia-associated anorexia.

Sato R, da Fonseca G, das Neves W, von Haehling S Pharmacol Res Perspect. 2025; 13(1):e70031.

PMID: 39776294 PMC: 11707257. DOI: 10.1002/prp2.70031.


Cognitive function is associated with performance in time up and go test and with leptin blood levels in community-dwelling older women.

Teixeira L, Soares L, Lima L, Avelar N, Moura J, Leopoldino A Sci Rep. 2024; 14(1):9841.

PMID: 38684691 PMC: 11058236. DOI: 10.1038/s41598-024-60274-5.


Mapping the causal associations of cytokines with sarcopenia and aging traits: Evidence from bidirectional Mendelian randomization.

Liu M, Fu X, Yu D, Li M, Pan Y, Yang C J Cachexia Sarcopenia Muscle. 2024; 15(3):1121-1133.

PMID: 38556722 PMC: 11154762. DOI: 10.1002/jcsm.13456.


Association of intrinsic capacity with functional ability, sarcopenia and systemic inflammation in pre-frail older adults.

Merchant R, Chan Y, Anbarasan D, Vellas B Front Med (Lausanne). 2024; 11:1374197.

PMID: 38510450 PMC: 10953915. DOI: 10.3389/fmed.2024.1374197.


Dysregulation of acyl carnitines, pentose phosphate pathway and arginine and ornithine metabolism are associated with decline in intrinsic capacity in Chinese older adults.

Pan Y, Li Y, Chhetri J, Liu P, Li B, Liu Z Aging Clin Exp Res. 2024; 36(1):36.

PMID: 38345670 PMC: 10861606. DOI: 10.1007/s40520-023-02654-x.


References
1.
Abdelmagid S, Barbe M, Safadi F . Role of inflammation in the aging bones. Life Sci. 2014; 123:25-34. DOI: 10.1016/j.lfs.2014.11.011. View

2.
Fujita Y, Taniguchi Y, Shinkai S, Tanaka M, Ito M . Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders. Geriatr Gerontol Int. 2016; 16 Suppl 1:17-29. DOI: 10.1111/ggi.12724. View

3.
Adriaensen W, Mathei C, Vaes B, Van Pottelbergh G, Wallemacq P, Degryse J . Interleukin-6 as a first-rated serum inflammatory marker to predict mortality and hospitalization in the oldest old: A regression and CART approach in the BELFRAIL study. Exp Gerontol. 2015; 69:53-61. DOI: 10.1016/j.exger.2015.06.005. View

4.
Moon J, Goeminne L, Kim J, Tian J, Kim S, Nga H . Growth differentiation factor 15 protects against the aging-mediated systemic inflammatory response in humans and mice. Aging Cell. 2020; 19(8):e13195. PMC: 7431835. DOI: 10.1111/acel.13195. View

5.
Gross A, Walker K, Moghekar A, Pettigrew C, Soldan A, Albert M . Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD. Front Aging Neurosci. 2019; 11:229. PMC: 6742958. DOI: 10.3389/fnagi.2019.00229. View